Figure 3
From: The functional −1019C/G HTR1A polymorphism and mechanisms of fear

BAT baseline to post-assessment. Means and s.e. of reported anxiety during anticipation period (a) and exposure period (b) and of tolerated duration of exposure during baseline and post-assessment (c) in 171 PD/AG patients randomized to one of two active treatment groups. BAT, behavioural avoidance test; PD/AG, panic disorder/agoraphobia.